Melanoma
Showing NaN - NaN of 66
Melanoma Trial in Worldwide (dacarbazine plus Genasense, dacarbazine plus )
Completed
- Melanoma
- dacarbazine plus Genasense
- dacarbazine plus placebo
-
Mobile, Alabama
- +76 more
Nov 4, 2011
Melanoma, Metastases Trial in Worldwide (MDX-010 (anti-CTLA4) mAb, MDX-1379 (gp100) Melanoma Peptide Vaccine)
Completed
- Melanoma
- Metastases
- MDX-010 (anti-CTLA4) monoclonal antibody
- MDX-1379 (gp100) Melanoma Peptide Vaccine
-
Tucson, Arizona
- +208 more
Jun 29, 2011
Melanoma Trial in Worldwide (ipilimumab (MDX-010, BMS-734016), Ipilimumab)
Completed
- Melanoma
- ipilimumab (MDX-010, BMS-734016)
- Ipilimumab
-
Tucson, Arizona
- +61 more
Feb 27, 2010
Breast Cancer, NSCLC, Melanoma Trial in United States (131-I-TM-601 (chlorotoxin))
Completed
- Breast Cancer
- +7 more
- 131-I-TM-601 (chlorotoxin)
-
Birmingham, Alabama
- +5 more
Mar 30, 2009
Melanoma, Skin Cancer Trial in United States (talabostat (PT-100) tablets, cisplatin)
Completed
- Melanoma
- Skin Cancer
- talabostat (PT-100) tablets
- cisplatin
-
Little Rock, Arkansas
- +12 more
Jun 7, 2007
Melanoma, Skin Cancer Trial in United States (talabostat (PT-100) tablets)
Completed
- Melanoma
- Skin Cancer
- talabostat (PT-100) tablets
-
Atlanta, Georgia
- +5 more
Jun 7, 2007